Carmel Capital Partners LLC Sells 1,313 Shares of HCA Healthcare, Inc. $HCA

Carmel Capital Partners LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 23.2% during the third quarter, according to its most recent filing with the SEC. The fund owned 4,343 shares of the company’s stock after selling 1,313 shares during the quarter. HCA Healthcare accounts for approximately 0.8% of Carmel Capital Partners LLC’s portfolio, making the stock its 29th largest holding. Carmel Capital Partners LLC’s holdings in HCA Healthcare were worth $1,851,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. iA Global Asset Management Inc. raised its holdings in shares of HCA Healthcare by 12.9% in the 3rd quarter. iA Global Asset Management Inc. now owns 45,064 shares of the company’s stock worth $19,206,000 after purchasing an additional 5,136 shares during the period. Strs Ohio lifted its position in shares of HCA Healthcare by 14.2% during the 3rd quarter. Strs Ohio now owns 90,280 shares of the company’s stock valued at $38,477,000 after buying an additional 11,242 shares during the last quarter. Simplicity Wealth LLC increased its holdings in HCA Healthcare by 26.5% in the 3rd quarter. Simplicity Wealth LLC now owns 2,275 shares of the company’s stock worth $970,000 after acquiring an additional 477 shares during the last quarter. Bailard Inc. purchased a new stake in HCA Healthcare during the third quarter valued at about $218,000. Finally, Avidian Wealth Enterprises LLC raised its position in shares of HCA Healthcare by 8.7% in the third quarter. Avidian Wealth Enterprises LLC now owns 854 shares of the company’s stock valued at $364,000 after purchasing an additional 68 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA stock opened at $466.10 on Friday. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $520.00. The stock has a market cap of $106.36 billion, a PE ratio of 18.02, a P/E/G ratio of 1.28 and a beta of 1.36. The firm has a 50 day simple moving average of $480.40 and a two-hundred day simple moving average of $432.89.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the business earned $4.90 earnings per share. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent research reports. Bank of America boosted their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a report on Monday, October 27th. The Goldman Sachs Group increased their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Truist Financial boosted their price objective on shares of HCA Healthcare from $495.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, January 5th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $488.75.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.